EP1802302
Ný notkun alfa-adrenvirkra efna með 2-imídasólín byggingu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.9.2005EP published:
26.10.2016EP application number:
05784163.7
EP translation filed:
24.1.2017Grant published:
15.2.2017EPO information:
European Patent Register
Max expiry date:
15.9.2025Expiry date:
15.9.2019
Title:
NOVEL USE OF alpha-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE
Timeline
Today
16.9.2005EP application
26.10.2016EP Publication
24.1.2017Translation submitted
15.2.2017Registration published
15.9.2019Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293, Darmstadt, DE
Inventor
Name:
SACHER, FritzAddress:
Gau-Algesheim, DE
Name:
TSCHAIKIN, MarionAddress:
Darmstadt, DE
Name:
KOELSCH, StephanAddress:
Worms, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
102004049008Date:
5.10.2004Country:
DE
Classification
Categories:
A61K 31/4174, A61P 31/16
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 9.8.2017
Expires: 15.9.2018
Payer: Árnason Faktor
Number: 14
Paid: 8.8.2018
Expires: 15.9.2019
Payer: Árnason Faktor